JP2022551918A5 - - Google Patents
Info
- Publication number
- JP2022551918A5 JP2022551918A5 JP2022521651A JP2022521651A JP2022551918A5 JP 2022551918 A5 JP2022551918 A5 JP 2022551918A5 JP 2022521651 A JP2022521651 A JP 2022521651A JP 2022521651 A JP2022521651 A JP 2022521651A JP 2022551918 A5 JP2022551918 A5 JP 2022551918A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- polypeptide
- composition according
- antigen
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025117198A JP2025148481A (ja) | 2019-10-09 | 2025-07-11 | マルチドメインタンパク質ワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962912903P | 2019-10-09 | 2019-10-09 | |
| US62/912,903 | 2019-10-09 | ||
| PCT/US2020/054785 WO2021072075A1 (en) | 2019-10-09 | 2020-10-08 | Multi-domain protein vaccine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025117198A Division JP2025148481A (ja) | 2019-10-09 | 2025-07-11 | マルチドメインタンパク質ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022551918A JP2022551918A (ja) | 2022-12-14 |
| JP2022551918A5 true JP2022551918A5 (https=) | 2023-10-17 |
| JP7712919B2 JP7712919B2 (ja) | 2025-07-24 |
Family
ID=75437582
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521651A Active JP7712919B2 (ja) | 2019-10-09 | 2020-10-08 | マルチドメインタンパク質ワクチン |
| JP2025117198A Pending JP2025148481A (ja) | 2019-10-09 | 2025-07-11 | マルチドメインタンパク質ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025117198A Pending JP2025148481A (ja) | 2019-10-09 | 2025-07-11 | マルチドメインタンパク質ワクチン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240317830A1 (https=) |
| EP (1) | EP4041295A4 (https=) |
| JP (2) | JP7712919B2 (https=) |
| KR (1) | KR20220110181A (https=) |
| CN (1) | CN114929264A (https=) |
| AU (1) | AU2020361515A1 (https=) |
| CA (1) | CA3156704A1 (https=) |
| WO (1) | WO2021072075A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023034901A1 (en) | 2021-09-01 | 2023-03-09 | The Broad Institute, Inc. | Tumor avatar vaccine compositions and uses thereof |
| WO2018085208A1 (en) | 2016-11-02 | 2018-05-11 | The Research Foundation For The State University Of New York | Methods of inhibiting viruses using compositions targeting tsg101-ubiquitin interaction |
| KR102818249B1 (ko) * | 2021-11-11 | 2025-06-10 | 의료법인 명지의료재단 | Kras 특이적 활성화 t 세포 유도용 항원 조성물을 이용한 항원 특이적 t 세포 유도방법 |
| KR102753583B1 (ko) * | 2021-11-11 | 2025-01-10 | 의료법인 명지의료재단 | Kras 특이적 활성화 t 세포 유도용 항원 조성물 |
| CN119563028A (zh) | 2022-05-12 | 2025-03-04 | 尚威天成信使核糖核酸治疗公司 | 具有分泌抗原和免疫调节物的合成自扩增mRNA分子 |
| KR20240017325A (ko) * | 2022-07-29 | 2024-02-07 | 주식회사 엘지화학 | 항원 전달용 재조합 융합 단백질 및 이의 이용 |
| WO2025147586A1 (en) * | 2024-01-05 | 2025-07-10 | Agilent Technologies, Inc. | Controlling antibody specificities in a polyclonal humoral response by epitope tuning |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2319828A1 (en) * | 1998-01-29 | 1999-08-05 | Miller, Samuel | High density arrays for proteome analysis and methods and compositions therefor |
| JP2002522091A (ja) * | 1998-08-17 | 2002-07-23 | フィロス インク． | ３’非翻訳領域を欠損する核酸を生成して細胞ｒｎａ蛋白質融合体形成を最適化する方法 |
| KR20050114225A (ko) * | 2003-03-07 | 2005-12-05 | 머크 앤드 캄파니 인코포레이티드 | 인플루엔자 바이러스 백신 |
| US20090075392A1 (en) | 2005-07-19 | 2009-03-19 | John Colyer | Agents for and method of quanitifying multiple related components in a biological system |
| GB0807065D0 (en) * | 2008-04-18 | 2008-05-21 | Univ Leeds | Novel scaffolds |
| IL260030B2 (en) * | 2016-01-08 | 2025-12-01 | Nykode Therapeutics ASA | Therapeutic anticancer neoepitope vaccine |
| WO2018135651A1 (ja) | 2017-01-20 | 2018-07-26 | 国立大学法人埼玉大学 | 抗体－多糖結合体及びそれを用いた高感度免疫測定方法 |
| KR102550778B1 (ko) * | 2017-05-26 | 2023-07-03 | 에이비비트로 엘엘씨 | 고-처리량 폴리뉴클레오타이드 라이브러리 시퀀싱 및 전사체 분석 |
| GB201710973D0 (en) | 2017-07-07 | 2017-08-23 | Avacta Life Sciences Ltd | Scaffold proteins |
| IL277128B2 (en) * | 2018-03-06 | 2025-11-01 | Precigen Inc | Hepatitis b vaccines and uses of the same |
-
2020
- 2020-10-08 KR KR1020227015031A patent/KR20220110181A/ko active Pending
- 2020-10-08 JP JP2022521651A patent/JP7712919B2/ja active Active
- 2020-10-08 CN CN202080083829.6A patent/CN114929264A/zh active Pending
- 2020-10-08 WO PCT/US2020/054785 patent/WO2021072075A1/en not_active Ceased
- 2020-10-08 AU AU2020361515A patent/AU2020361515A1/en active Pending
- 2020-10-08 CA CA3156704A patent/CA3156704A1/en active Pending
- 2020-10-08 US US17/767,791 patent/US20240317830A1/en active Pending
- 2020-10-08 EP EP20874481.3A patent/EP4041295A4/en active Pending
-
2025
- 2025-07-11 JP JP2025117198A patent/JP2025148481A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022551918A5 (https=) | ||
| US20230384320A1 (en) | Hla-based methods and compositions and uses thereof | |
| JP6527918B2 (ja) | 第ｖｉｉｉ因子組成物、ならびに組成物の作製方法および用途 | |
| JP7082051B2 (ja) | 抗原特異的ｃｄ８＋ｔ細胞の産生におけるインターロイキン－１０及びその使用方法 | |
| JP6206972B2 (ja) | グルカゴン様ペプチド−２組成物およびその作製法および使用法 | |
| KR101813727B1 (ko) | 성장 호르몬 폴리펩타이드 및 이를 제조하고 사용하는 방법 | |
| TWI710570B (zh) | 用於治療代謝異常之組成物及方法 | |
| JP2012520059A5 (https=) | ||
| JP2002514658A (ja) | β−アミロイド前駆体タンパク質およびユビキチンＢのフレームシフト変異体ならびにその使用 | |
| JP2019506843A5 (https=) | ||
| JP2019513021A (ja) | ネオエピトープ提示のための配列の配置および配列 | |
| US12611449B2 (en) | Individualized vaccines for cancer | |
| JP2022551918A (ja) | マルチドメインタンパク質ワクチン | |
| CN117279660A (zh) | 经修饰的甲病毒载体 | |
| JP2006505252A (ja) | 抗原およびアジュバントの多量体複合体 | |
| US20070092933A1 (en) | Production of multimeric fusion proteins using a c4bp scaffold | |
| JP4299777B2 (ja) | 免疫応答を誘導するための方法および組成物 | |
| CN114450303B (zh) | Mhc ii类分子及其使用方法 | |
| ES3016662T3 (en) | Binding molecules specfic for hbv envelope protein | |
| JP2004533845A (ja) | ポリペプチドの免疫原性を低減する方法 | |
| US20050277575A1 (en) | Therapeutic compositions and methods for treating diseases that involve angiogenesis | |
| WO2025122957A1 (en) | Protease activatable cytokines and methods for making and using the same | |
| WO2022174151A1 (en) | Prophylactic broad spectrum vaccine for sars-cov-2 | |
| JP2022501373A (ja) | 改善された第ｖｉｉｉ因子長期半減期凝固複合体に関連する方法および組成物 | |
| JP2007319069A (ja) | ＬＯＣ２８４２９３バリアント遺伝子並びに該遺伝子がコードするＣＤ８＋細胞傷害性Ｔリンパ球ｍＨＡエピトープペプチド及びその用途 |